申请人:Eisai R&D Management Co., Ltd.
公开号:US20140243316A1
公开(公告)日:2014-08-28
A compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof works as an mGluR2 antagonist, and is applicable as a therapeutic agent for neurological disorders related to glutamate dysfunction and diseases involving the mGluR2, such as Alzheimer's disease:
wherein R is a hydrogen atom, a C
1-6
alkyl group or the like, R
1
is a C
1-6
alkyl group, a C
1-6
alkoxy group or the like, R
2
is a halogen atom, a C
1-6
alkyl group, a C
1-6
alkoxy group or the like, R
3
is a hydrogen atom, a C
1-6
alkyl group or the like, and R
4
is a C
1-6
alkyl group or the like.
以下公式(I)表示的化合物或其药用可接受盐作为mGluR2拮抗剂,可用作治疗与谷氨酸功能障碍相关的神经疾病和涉及mGluR2的疾病,如阿尔茨海默病:其中R是氢原子、C1-6烷基或类似物,R1是C1-6烷基、C1-6甲氧基或类似物,R2是卤素原子、C1-6烷基、C1-6甲氧基或类似物,R3是氢原子、C1-6烷基或类似物,R4是C1-6烷基或类似物。